China CAS NO:668270-12-0 Factory

We'll make each hard work to become excellent and excellent, and speed up our measures for standing from the rank of intercontinental top-grade and high-tech enterprises for CAS NO:668270-12-0,Linagliptin API,Linagliptin, Welcome any inquiry to our firm. We're going to be glad to establish pleasant business interactions with you!
CAS NO:668270-12-0, We always insist on the principle of "Quality and service are the life of the product". Till now, our products have been exported to more than 20 countries under our strict quality control and high level service.

Hot Products

  • 3,5-Bis(2-cyanoprop-2-yl)benzyl bromide

    3,5-Bis(2-cyanoprop-2-yl)benzyl bromide

    Product Name:3,5-Bis(2-cyanoprop-2-yl)benzyl bromide
    Molecular Formula:C15H17BrN2
    Molecular Weight:305.21
    CAS Registry Number:120511-84-4
  • 2-Benzoylpyrrole

    2-Benzoylpyrrole

    Name:2-Benzoylpyrrole Synonyms:Phenyl(1H-pyrrol-2-yl)methanone Molecular Formula:C11H9NO Molecular Weight:171.19 CAS Registry Number:7697-46-3
  • 3-Ethoxy-4-methoxy benzonitrile

    3-Ethoxy-4-methoxy benzonitrile

    Product Name:3-Ethoxy-4-methoxy benzonitrile
    Molecular Formula:C10H11NO2
    Molecular Weight:177.2
    CAS Registry Number:60758-86-3
  • 3-Chloro-2-fluoroaniline

    3-Chloro-2-fluoroaniline

    Product Name:3-Chloro-2-fluoroaniline
    Molecular Formula:C6H5ClFN
    Molecular Weight:145.56
    CAS Registry Number:2106-04-9
  • Remdesivir

    Remdesivir

    Product Name:Remdesivir
    Molecular Formula:C27H35N6O8P
    Molecular Weight;602.58
    CAS Registry Number;1809249-37-3
  • (6-aMinopyridin-2-yl)(1-Methylpiperidin-4-yl)Methanone

    (6-aMinopyridin-2-yl)(1-Methylpiperidin-4-yl)Methanone

    Product Name:(6-aMinopyridin-2-yl)(1-Methylpiperidin-4-yl)Methanone
    Molecular Formula:C12H17N3O
    Molecular Weight:219.28
    CAS Registry Number:613678-03-8

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept